What is this?

HISWAI shows you what’s connected to topics that interest you, and where to find more. HISWAI members can curate information with dashboards to gain insights, proper context and stay up to date on the latest relevant information. Sharing these discoveries with others is easy too!

help

Want to know more?

Darktrace confirms early takeover talks with PE firm Thoma Bravo - TechMarketView

< Go Back

Date: 2022-08-16 08:48:41

Tags for this article:

Article Text:

Tuesday 16 August 2022

DarktraceUS based private equity firm Thoma Bravo is considering a bid to privatise UK listed cybersecurity firm Darktrace. Discussions are at a preliminary stage and there can be no certainty that any offer will be made. No terms of a proposed deal have currently been disclosed. The private equity group will have until September 12th to either make a formal offer or abandon the takeover effort. Darktrace shares rose 20% this morning on the news.

Thoma Bravo, with $114bn in assets, is one of the world’s most active investors in cyber security companies, with a specialised set of dealmakers targeting the sector. Earlier this month they announced the acquisition of US based Identify solution provider Ping Identity for $2.8bn, and in April they bought cybersecurity provider Proofpoint for $12.3bn – see here. They also own UK security software company Sophos which they bought in 2020.

Thomas Bravo also continues to invest in other technology segments, with a $10.7bn acquisition of business planning software company Anaplan announced in March and Banking and payments specialist, Bottomline Technologies which it bought for $2.6bn in December.

If the deal goes through this would be a loss off another technology heavy hitter being removed from the LSE, to join the likes of Avast, who announced in early August a merger with US software company Norton LifeLock see here. It should not come as a huge surprise however that Darktrace is an attractive target, they posted 48% revenue growth for FY22 (see here) and shares trade at a significantly lower valuation to its US listed peers.